Related Experiment Video
Updated: Aug 7, 2026
07:25
Assessing Murine Resistance Artery Function Using Pressure Myography
Published on: June 7, 2013
Major new developments affecting treatment and prognosis in hypertension
Transactions of the Association of Life Insurance Medical Directors of America
|January 1, 1990
Summary
Newer hypertension drugs like ACE inhibitors and calcium blockers effectively lower blood pressure and reduce left ventricular hypertrophy, improving cardiovascular outcomes. These medications offer better compliance and fewer side effects than older treatments.
Area of Science:
- Cardiology
- Pharmacology
- Hypertension Research
Background:
- Established link between elevated blood pressure and cardiovascular mortality.
- Previous antihypertensive drug trials (diuretics, vasodilators, beta-blockers) showed limited success in reducing cardiac mortality and sudden death.
- Concerns regarding side effects of older drugs, including metabolic disturbances and arrhythmias.
Purpose of the Study:
- To investigate recent changes in hypertension drug prescription patterns.
- To evaluate the impact of newer antihypertensive agents on cardiovascular health.
- To assess the role of left ventricular hypertrophy in hypertension and its potential regression.
Main Methods:
- Survey of 674 hypertensive patients and their physicians from 1985-1989.
- Analysis of drug prescription trends, focusing on angiotensin-converting enzyme (ACE) inhibitors and calcium blockers.
- Review of the physiological effects of different drug classes on blood pressure and left ventricular hypertrophy.
Main Results:
- Significant increase in the popularity of ACE inhibitors and calcium blockers during the study period.
- These newer drug classes effectively lower blood pressure with minimal side effects and good patient compliance.
- ACE inhibitors and calcium blockers demonstrate the ability to regress left ventricular hypertrophy, unlike older medications.
Conclusions:
- Angiotensin-converting enzyme inhibitors and calcium blockers represent a significant advancement in hypertension management.
- Their efficacy in reducing blood pressure and regressing left ventricular hypertrophy offers improved cardiovascular protection.
- These newer agents portend a major positive change in the outlook for patients with hypertension.
Related Concept Videos
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
01:23Hypertension V: Nursing Management
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.